Cargando…
Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disease that primarily affects elderly individuals. Recent studies have found that sigma-1 receptor (S1R) agonists can maintain endoplasmic reticulum stress homeostasis, reduce neuronal apoptosis, and enhance mitochondrial function and autophagy, makin...
Autores principales: | Wu, Xialin, Li, Zhuojian, Chen, Guanxing, Yin, Yiyang, Chen, Calvin Yu-Chian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334190/ https://www.ncbi.nlm.nih.gov/pubmed/37441162 http://dx.doi.org/10.3389/fmolb.2023.1227371 |
Ejemplares similares
-
NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction
por: He, Haohuai, et al.
Publicado: (2023) -
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters
por: Roy, Shuvra Shekhar, et al.
Publicado: (2023) -
Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach
por: de Felice, Alessandra, et al.
Publicado: (2021) -
Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy
por: Zhang, Jinping, et al.
Publicado: (2022) -
Learned features of antibody-antigen binding affinity
por: Miller, Nathaniel L., et al.
Publicado: (2023)